On this week’s Tech Nation, Moira speaks with Jamie Susskind about his book, “The Digital Republic … On Freedom and Democracy in the 21st Century”. Then, in Biotech, a potential successor to stem cells - fibroblasts? Yes, fibroblasts. Dr. Hamid Khoja, Chief Scientific Officer of FibroBiologics in Houston, describes their fibroblast programs in such diverse conditions as Degenerative Disk Disease, Multiple Sclerosis and Diabetic Foot Ulcers.